Calpain Overactivation and Offspring Cognition After Surgery
2026-09-08
A 2025 Neuropharmacology study identifies excessive calpain activity as a mechanistic link between maternal non-obstetric surgery during pregnancy and later offspring cognitive deficits. Its intervention data suggest that postnatal calpain inhibition or TrkB activation can partially restore hippocampal synaptic markers, neuronal structure, and behavioral performance.
Azilsartan medoxomil monopotassium: Assay Guide
2026-09-08
Build reproducible AT1-receptor assays with Azilsartan medoxomil monopotassium (TAK 491), from DMSO stock preparation through pathway-specific functional readouts. The workflow combines nanomolar pharmacology with a clinically informed interpretation of angiotensin II vasopressor data without confusing receptor blockade with direct vasopressor conversion.
KU-60019: ATM Signaling at the Translational Edge
2026-09-07
A mechanistic and translational analysis of KU-60019 as a selective ATM kinase inhibitor for glioma radiosensitization, with strategic guidance for pathway validation, assay design, and responsible cross-domain interpretation.
Dihydroartemisinin: Applied Research Workflows
2026-09-05
Build reproducible Dihydroartemisinin assays for mTOR-linked cell studies, inflammation models, and malaria research without confusing compound identity with evidence from related antiplasmodial inhibitors. This practical guide combines handling parameters, assay design, comparative interpretation, and troubleshooting for SKU N1713.
ERK5 and Vitamin D–Induced AML Differentiation
2026-09-05
The reference study separates the roles of ERK5 and ERK1/2 in 1α,25-dihydroxyvitamin D3-driven differentiation of acute myeloid leukemia cells. Its inhibitor-based experiments connect ERK5 activity with distinct differentiation-marker patterns and cell-cycle arrest, while showing that MEK–ERK1/2 blockade produces a broader loss of differentiation responses.
Sabutoclax in Reliable Apoptosis Assays
2026-09-04
This scenario-based guide explains how Sabutoclax (SKU A4199) can support better-designed viability, proliferation, and apoptosis experiments. It connects pan-Bcl-2 pharmacology with practical controls, compound handling, dose-response interpretation, and evidence-based supplier selection.
Protease Inhibitor Cocktail EDTA-Free: Workflow Guide
2026-09-04
This guide explains how to use the EDTA-free, 100X-in-DMSO formulation to limit endogenous proteolysis during protein extraction and sample preparation. It is suited to Western blotting, co-immunoprecipitation, pull-down, phosphorylation-sensitive, and enzyme workflows, but it is not a universal substitute for phosphatase inhibition or assay-specific compatibility testing.
2X Taq PCR Master Mix for Genotyping
2026-09-03
Streamline routine genotyping, cloning, and gel analysis with a ready-to-use mix that combines Taq amplification chemistry and direct-loading dye. Its adenine-overhang products support TA cloning, while a disciplined PCR workflow can help molecular assays validate field-based disease observations.
Tropifexor (LJN452) FXR Research Workflows
2026-09-03
Tropifexor (LJN452) provides a highly potent, receptor-focused way to interrogate FXR biology in intestinal barrier, liver, and metabolic disease models. This workflow-led guide connects FXR activation with practical assay design while separating validated product properties from research starting conditions.
CCG-1423: RhoA Inhibitor Workflow Guide
2026-09-02
CCG-1423 helps separate MRTF-A-dependent transcriptional signaling from the contractile effects of the RhoA/ROCK pathway. This practical guide translates recent MVC infection findings into research workflows for cancer research, viral pathogenesis, imaging, proliferation, invasion, and apoptosis assay design.
Nav1.5 Ser571 Links Aging to Late Na+
2026-09-02
The 2024 reference study identifies Nav1.5 phosphorylation at Ser571 as a mechanistic link between increased late sodium current, delayed ventricular repolarization, and age-related diastolic dysfunction. By combining age comparisons with phosphomimetic and phosphoablated mouse models, the work shows that late sodium current is not merely an electrophysiological correlate of aging but a modifiable contributor to impaired myocardial relaxation.
GCN2 Surveillance of Translation Termination
2026-09-01
Worner et al. identify GCN2 as a rapid surveillance kinase that detects compromised translation termination before ribosome collisions become prominent. Using acute eRF1 depletion, rescue experiments, and ribosome profiling in mouse and human cells, the study shows that GCN2-eIF2α signaling suppresses new translation initiation, limiting collisions and stop-codon readthrough.
PGF2α/PTGFR Signaling in Endometrial Breakdown
2026-08-31
This 2024 mouse menstrual-like model study identifies PGF2α/PTGFR as a functional link between progesterone withdrawal, endometrial disintegration, and vascular remodeling, with HIF-1α directly associated with Ptgfr promoter regulation. Its combined pharmacological, molecular, histological, and human-cell evidence provides a framework for dissecting prostaglandin signaling during menstruation while highlighting the limits of translating mouse vascular findings to human physiology.
AL-8810: Prostaglandin F2α Antagonist Workflows
2026-08-31
AL-8810 enables receptor-level dissection of PGF2α responses in endometrial, vascular, smooth-muscle, and ocular cell models. This guide translates the reference study into practical treatment designs, readouts, controls, and troubleshooting strategies for reproducible FP receptor research.
HyperScript™ Reverse Transcriptase for RNA Assays
2026-08-30
Discover how HyperScript™ Reverse Transcriptase can strengthen RNA to cDNA conversion when fusion transcripts, low-input samples, or structured RNA challenge RT-qPCR. This article translates findings from an FGFR2 fusion study into practical assay-design decisions without conflating enzyme performance with biological treatment efficacy.
460 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page